| Issue Date | Title | Author(s) |
| 2008-11-27 | Chlamydia trachomatis responds to heat shock, penicillin induced persistence, and IFN-gamma persistence by altering levels of the extracytoplasmic stress response protease HtrA | Huston, WM; Theodoropoulos, C; Mathews, SA; Timms, P |
| 2013-01-01 | Cathelicidin-like Helminth Defence Molecules (HDMs): Absence of Cytotoxic, Anti-microbial and Anti-protozoan Activities Imply a Specific Adaptation to Immune Modulation | Thivierge, K; Cotton, S; Schaefer, DA; Riggs, MW; To, J; Lund, ME; Robinson, MW; Dalton, JP; Donnelly, SM |
| 2013-08-17 | A cohort study of Chlamydia trachomatis treatment failure in women: A study protocol | Hocking, JS; Vodstrcil, LA; Huston, WM; Timms, P; Chen, MY; Worthington, K; McIver, R; Tabrizi, SN |
| 2013-12-01 | The protease inhibitor JO146 demonstrates a critical role for CtHtrA for Chlamydia trachomatis reversion from penicillin persistence | Ong, VA; Marsh, JW; Lawrence, A; Allan, JA; Timms, P; Huston, WM |
| 2013-08-01 | Identification of a serine protease inhibitor which causes inclusion vacuole reduction and is lethal to Chlamydia trachomatis | Gloeckl, S; Ong, VA; Patel, P; Tyndall, JDA; Timms, P; Beagley, KW; Allan, JA; Armitage, CW; Turnbull, L; Whitchurch, CB; Merdanovic, M; Ehrmann, M; Powers, JC; Oleksyszyn, J; Verdoes, M; Bogyo, M; Huston, WM |
| 2018-03-02 | Defining the distinct, intrinsic properties of the novel type i interferon, IFNϵ | Stifter, SA; Matthews, AY; Mangan, NE; Fung, KY; Drew, A; Tate, MD; Soares Da Costa, TP; Hampsey, D; Mayall, J; Hansbro, PM; Minambres, AG; Eid, SG; Mak, J; Scoble, J; Lovrecz, G; DeWeerd, NA; Hertzog, PJ |
| 2019-07-31 | New therapeutic targets for the prevention of infectious acute exacerbations of COPD: Role of epithelial adhesion molecules and inflammatory pathways | Atto, B; Eapen, MS; Sharma, P; Frey, U; Ammit, AJ; Markos, J; Chia, C; Larby, J; Haug, G; Weber, HC; Mabeza, G; Tristram, S; Myers, S; Geraghty, DP; Flanagan, KL; Hansbro, PM; Sohal, SS |
| 2020-01 | Diversity profiling of xenic cultures of Dientamoeba fragilis following systematic antibiotic treatment and prospects for genome sequencing. | Gough, R; Barratt, J; Stark, D; Ellis, J |
| 2017-10-01 | Copper(II)-bis(thiosemicarbazonato) complexes as anti-chlamydial agents | Marsh, JW; Djoko, KY; McEwan, AG; Huston, WM |
| 2017-07-01 | CtHtrA: The lynchpin of the chlamydial surface and a promising therapeutic target | Marsh, JW; Ong, VA; Lott, WB; Timms, P; Tyndall, JDA; Huston, WM |
